Tag: cardiovascular-kidney-metabolic
-
A Preprint Estimates the 2026 CKM Guideline Newly Qualifies 7.5 Million US Adults for GLP-1 Receptor Agonists, Mostly Overweight Adults Without Comorbidity; “Zero New SGLT2 Inhibitor Candidates” Is a Product of the Comparator Definition
A Preprint Estimates the 2026 CKM Guideline Newly Qualifies 7.5 Million US Adults for GLP-1 Receptor Agonists, Mostly Overweight Adults Without Comorbidity; “Zero New SGLT2 Inhibitor Candidates” Is a Product of the Comparator Definition Analysis based on information available as of 2026-11-03. 30-second summary What: A not-yet-peer-reviewed preprint (Corsi et al., medRxiv, posted 2026-10-26) applied…
